NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Richard Keenan, PhD

Practice Area Focus

  • Development Strategy
  • CMC


Richard Keenan, PhD, has been an Expert Consultant with NDA Partners since 2014. He is an experienced drug discovery executive with more than 25 years of experience in medicinal chemistry in a variety of therapeutic areas, and has contributed directly to the discovery of numerous clinical development compounds.

Prior to joining NDA Partners, he was the Vice President, Center of Excellence for External Drug Discovery (CEEDD) at GlaxoSmithKline (GSK) where he was responsible for R&D externalization within the company. As Director of Medicinal Chemistry in GSK, he was responsible for a group of more than 40 medicinal chemists in Microbiology, Musculoskeletal, and Proliferative Disease. His responsibilities included lead optimization, and identification of clinical candidates for bacterial infections, chemoprotection, and cancer.

Dr. Keenan served for more than 15 years in the Department of Medicinal Chemistry at SmithKline Beecham Pharmaceuticals in a variety of senior executive roles, where he led medicinal chemistry research efforts on enzyme and receptor targets in cardiovascular, antiviral, host-defense, bone, and inflammation therapeutic areas.